Medtronic Plc Stock Performance
| MDT Stock | USD 80.38 0.91 1.12% |
The company secures a Beta (Market Risk) of 0.99, which conveys possible diversification benefits within a given portfolio. Medtronic PLC returns are very sensitive to returns on the market. As the market goes up or down, Medtronic PLC is expected to follow. Medtronic PLC has an expected return of -0.0999%. Please make sure to verify Medtronic PLC treynor ratio, as well as the relationship between the kurtosis and day typical price , to decide if Medtronic PLC performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Medtronic PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Medtronic PLC is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Actual Historical Performance (%)
One Day Return (1.09) | Five Day Return 1.09 | Year To Date Return (2.95) | Ten Year Return 37.81 | All Time Return 25.5 K |
Forward Dividend Yield 0.034 | Payout Ratio 0.5188 | Last Split Factor 2:1 | Forward Dividend Rate 2.76 | Dividend Date 2024-04-12 |
1 | Johnson Johnson Makes Yet Another Multi-Billion MedTech Deal With Shockwave Medical | 04/05/2024 |
2 | OM1, Medtronic partner on drug-eluting implant study | 04/09/2024 |
3 | Here Are My Top Artificial Intelligence Stocks to Buy Now | 04/11/2024 |
| Medtronic PLC dividend paid on 12th of April 2024 | 04/12/2024 |
4 | Abbotts latest Heartmate recall tied to 273 injuries, 14 deaths | 04/15/2024 |
5 | Radians appoints Cal Bontemps as Director of Marketing | 04/16/2024 |
6 | Gustavus Adolphus College President Rebecca Bergman Announces Retirement | 04/17/2024 |
7 | Medtronic unveils new AI for laparoscopic, robotic surgery tech | 04/18/2024 |
8 | 21 Manufacturers Among Top 50 Large Workplaces to Grow Careers | 04/19/2024 |
9 | Tactile Medical names Sheri Dodd as new CEO, Q1 revenue rises | 04/23/2024 |
| Begin Period Cash Flow | 3.7 B | |
| Total Cashflows From Investing Activities | -3.5 B |
Medtronic |
Medtronic PLC Relative Risk vs. Return Landscape
If you would invest 8,583 in Medtronic PLC on January 26, 2024 and sell it today you would lose (545.00) from holding Medtronic PLC or give up 6.35% of portfolio value over 90 days. Medtronic PLC is generating negative expected returns assuming volatility of 1.0883% on return distribution over 90 days investment horizon. In other words, 9% of stocks are less volatile than Medtronic, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Medtronic PLC Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medtronic PLC's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Medtronic PLC, and traders can use it to determine the average amount a Medtronic PLC's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0918
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MDT |
Estimated Market Risk
| 1.09 actual daily | 9 91% of assets are more volatile |
Expected Return
| -0.1 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Medtronic PLC is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medtronic PLC by adding Medtronic PLC to a well-diversified portfolio.
Medtronic PLC Fundamentals Growth
Medtronic Stock prices reflect investors' perceptions of the future prospects and financial health of Medtronic PLC, and Medtronic PLC fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medtronic Stock performance.
| Return On Equity | 0.0817 | ||||
| Return On Asset | 0.0423 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.19 % | ||||
| Current Valuation | 125 B | ||||
| Shares Outstanding | 1.33 B | ||||
| Price To Earning | 20.44 X | ||||
| Price To Book | 2.05 X | ||||
| Price To Sales | 3.29 X | ||||
| Revenue | 31.23 B | ||||
| Gross Profit | 21.71 B | ||||
| EBITDA | 9.04 B | ||||
| Net Income | 3.78 B | ||||
| Cash And Equivalents | 1.54 B | ||||
| Cash Per Share | 8.59 X | ||||
| Total Debt | 24.36 B | ||||
| Debt To Equity | 0.51 % | ||||
| Current Ratio | 1.76 X | ||||
| Book Value Per Share | 38.95 X | ||||
| Cash Flow From Operations | 6.04 B | ||||
| Earnings Per Share | 3.15 X | ||||
| Market Capitalization | 107.94 B | ||||
| Total Asset | 90.95 B | ||||
| Retained Earnings | 30.39 B | ||||
| Working Capital | 12.62 B | ||||
| Current Asset | 23.6 B | ||||
| Current Liabilities | 7.17 B | ||||
About Medtronic PLC Performance
To evaluate Medtronic PLC Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Medtronic PLC generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Medtronic Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Medtronic PLC market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Medtronic's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 150.17 | 197.15 | |
| Return On Tangible Assets | 0.11 | 0.18 | |
| Return On Capital Employed | 0.05 | 0.05 | |
| Return On Assets | 0.04 | 0.04 | |
| Return On Equity | 0.07 | 0.07 |
Things to note about Medtronic PLC performance evaluation
Checking the ongoing alerts about Medtronic PLC for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Medtronic PLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Medtronic PLC generated a negative expected return over the last 90 days | |
| Over 85.0% of the company shares are owned by institutional investors | |
| On 12th of April 2024 Medtronic PLC paid $ 0.69 per share dividend to its current shareholders | |
| Latest headline from investing.com: Tactile Medical names Sheri Dodd as new CEO, Q1 revenue rises |
- Analyzing Medtronic PLC's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medtronic PLC's stock is overvalued or undervalued compared to its peers.
- Examining Medtronic PLC's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medtronic PLC's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medtronic PLC's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Medtronic PLC's stock. These opinions can provide insight into Medtronic PLC's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.Note that the Medtronic PLC information on this page should be used as a complementary analysis to other Medtronic PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Medtronic Stock analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |
Is Medtronic PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medtronic PLC. If investors know Medtronic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medtronic PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.078 | Dividend Share 2.75 | Earnings Share 3.15 | Revenue Per Share 24.298 | Quarterly Revenue Growth 0.047 |
The market value of Medtronic PLC is measured differently than its book value, which is the value of Medtronic that is recorded on the company's balance sheet. Investors also form their own opinion of Medtronic PLC's value that differs from its market value or its book value, called intrinsic value, which is Medtronic PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medtronic PLC's market value can be influenced by many factors that don't directly affect Medtronic PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medtronic PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medtronic PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medtronic PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.